"Artificial Intelligence + Healthcare" welcomes new policies, multiple listed companies are expected to benefit

On November 4th, the National Health Commission issued the "Implementation Opinions on Promoting and Regulating the Development of 'Artificial Intelligence + Healthcare' Applications." Reporters noted that a number of A-share companies, including SWS Medical, Yunnan Baiyao, and EASEPAL, have already made early layouts in different industrial tracks of "Artificial Intelligence + Healthcare." The "Implementation Opinions" further clarify the direction of industrial support and key application areas, which will bring new opportunities for business expansion for related listed companies and help them create new performance growth points. (Shanghai Securities Journal)